Citizens reiterates Amentum stock rating on defense capabilities By Investing.com

Citizens reiterated a Market Outperform rating on Amentum Holdings with a $40 price target, implying about 52% upside from the current $26.29 share price. The firm highlighted Amentum’s post-merger positioning, attractive valuation, and exposure to defense and nuclear growth themes, including AI-driven power demand and regulatory tailwinds. Recent contract wins total roughly $518 million, including a $406 million UK small modular reactor award and a $112 million European Commission decommissioning contract.

Analysis

The market is still underpricing how much of this move is about policy, not just headline prices. A sustained energy shock here is a two-sided catalyst: it improves the case for U.S. and allied nuclear buildout, but it also tightens capital allocation across industrial end-markets, which can delay discretionary defense and infrastructure spend. Amentum’s cleaner angle is that it sits in the “government outsourcing” bucket with exposure to budget priorities that usually get protected when agencies re-rank spending around energy security and strategic autonomy.

The second-order winner is not necessarily the obvious reactor OEMs; it is the picks-and-shovels layer that monetizes engineering, permitting, decommissioning, and program management before large-scale capacity additions hit the ground. That should support multiple expansion for contractors with nuclear credibility, but only if investors believe these are multi-year programs rather than one-off awards. The key watch item is backlog quality: if recent wins convert into a higher mix of recurring advisory and owner’s-engineer work, margin durability should improve; if not, the market will fade the story as cyclical contract noise.

The main contrarian risk is that the narrative has become too linear: “higher power demand = immediate nuclear boom.” In reality, permitting, financing, grid interconnection, and labor constraints mean the earnings uplift is lagged, likely showing up over 12-36 months rather than this quarter. That creates room for a tactical dislocation if the stock has already discounted a perfect execution path. Also, any de-escalation in Iran or policy relief that caps oil would quickly cool urgency around energy-security spending.

From a trading perspective, this is more attractive as a relative-value expression than a standalone long: the cleanest setup is long AMTM versus a defense prime or industrial services name with less nuclear/energy optionality. The asymmetry improves on pullbacks toward the low- to mid-20s, where investors can own the multi-year optionality with a contained drawdown if the contract flow slows. If oil volatility persists, Amentum should trade like a “budget beta plus nuclear call option,” but if energy markets normalize, the multiple can compress fast.

Key Decisions for Investors

• Initiate a tactical long AMTM on weakness toward the mid-$20s for a 3-6 month horizon; use a stop below the post-merger valuation support area, because the thesis breaks if contract wins stop being translated into backlog growth.
• Pair trade: long AMTM / short an infrastructure or defense contractor with less nuclear exposure (e.g., HII or TEX) over 6-12 months; the relative value is in nuclear policy optionality, not broad defense beta.
• Buy AMTM Jan-2026 calls or call spreads to express the 12-24 month nuclear-buildout thesis while limiting downside if permitting and financing delays push revenue recognition out.
• Take profits into strength if AMTM re-rates toward the low-$40s quickly; that would likely price in near-perfect execution and leave limited upside unless order intake accelerates materially.